Correlation Between Dr Reddys and Viatris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dr Reddys and Viatris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and Viatris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dr Reddys Laboratories and Viatris, you can compare the effects of market volatilities on Dr Reddys and Viatris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of Viatris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and Viatris.

Diversification Opportunities for Dr Reddys and Viatris

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between RDY and Viatris is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and Viatris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viatris and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with Viatris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viatris has no effect on the direction of Dr Reddys i.e., Dr Reddys and Viatris go up and down completely randomly.

Pair Corralation between Dr Reddys and Viatris

Considering the 90-day investment horizon Dr Reddys Laboratories is expected to generate 0.72 times more return on investment than Viatris. However, Dr Reddys Laboratories is 1.39 times less risky than Viatris. It trades about 0.07 of its potential returns per unit of risk. Viatris is currently generating about 0.03 per unit of risk. If you would invest  960.00  in Dr Reddys Laboratories on September 18, 2024 and sell it today you would earn a total of  486.00  from holding Dr Reddys Laboratories or generate 50.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dr Reddys Laboratories  vs.  Viatris

 Performance 
       Timeline  
Dr Reddys Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Viatris 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Dr Reddys and Viatris Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dr Reddys and Viatris

The main advantage of trading using opposite Dr Reddys and Viatris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, Viatris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viatris will offset losses from the drop in Viatris' long position.
The idea behind Dr Reddys Laboratories and Viatris pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated